Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Blue Cross and Blue Shield of Massachusetts, Inc., et al. v. Takeda Pharmaceuticals America Inc. et al
Case Number:
1:17-cv-11660
Court:
Nature of Suit:
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability
Judge:
Firms
Companies
Sectors & Industries:
-
March 07, 2018
Blue Cross, Takeda Settle Actos Cancer Claims
Blue Cross and Blue Shield of Massachusetts and drug manufacturer Takeda Pharmaceutical Co. Ltd. told a Massachusetts federal court on Wednesday they have settled dozens of claims by the insurer alleging that a link between Actos and bladder cancer was long known to Takeda, the latest in a long string of settlements involving the diabetes treatment.
-
November 20, 2017
Deal Expected In Insurer's Actos Cancer Suit Against Takeda
Dozens of claims from Blue Cross and Blue Shield of Massachusetts alleging that a link between diabetes treatment Actos and bladder cancer was long known to drug manufacturer Takeda are expected to head for arbitration separate from a $2.4 billion settlement with patients, a Boston federal judge said Monday.